Study Population. This retrospective, single-center study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Ethics Committee of Fudan University Shanghai Cancer Center. Informed consent was obtained from all individual participants. From March 2017 to June 2022, 147 patients who underwent RP after neoadjuvant ADT and presurgical MRI examinations were retrieved from our picture archiving and communication system according to the following criteria 147 PCa patients undergoing ADT before RP Inclusion • Clinically significant PCa as confirmed by biopsy before ADT • With post-ADT pathology confirmed by RP • Mp-MRI scans within 2 weeks before RP • More than 3 months with a complete androgen blockade with bicalutamide plus ADT Final study population (n=119) Exclusion • Any type of chemotherapy or RT before RP (n=18) • Inadequate image quality (n=10) (Figure 1).
Appears in 3 contracts
Samples: Diagnostic Efficacy and Interobserver Agreement Study, Research Article, Diagnostic Efficacy and Interobserver Agreement Study
Study Population. This retrospective, single-center study was conducted in accordance with the Declaration of Helsinki (as revised in 2013) and was approved by the Ethics Committee of Fudan University Shanghai Cancer Center. Informed consent was obtained from all individual participants. From March 2017 to June 2022, 147 patients who underwent RP after neoadjuvant ADT and presurgical MRI examinations were retrieved from our picture archiving and communication system according to the following criteria 147 PCa patients undergoing ADT before RP Inclusion • Clinically significant PCa as confirmed by biopsy before ADT • With post-ADT pathology confirmed by RP • Mp-MRI scans within 2 weeks before RP • More than 3 months with a complete androgen blockade with bicalutamide plus ADT Final study population (n=119) Exclusion • Any type of chemotherapy or RT before RP (n=18) • Inadequate image quality (n=10) (Figure 1).
Appears in 1 contract
Samples: Research Article